Načítá se...

Sequencing of nontransplant treatments in multiple myeloma patients with active disease

The approval of several different classes of drugs in recent years has resulted in a dramatic expansion of treatment options for multiple myeloma patients, improving both survival and quality of life. Lenalidomide and bortezomib are now core components of treatment both at time of diagnosis and at r...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Hematology Am Soc Hematol Educ Program
Hlavní autoři: Yee, Andrew J., Raje, Noopur S.
Médium: Artigo
Jazyk:Inglês
Vydáno: American Society of Hematology 2016
Témata:
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6142445/
https://ncbi.nlm.nih.gov/pubmed/27913521
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!